Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MRCP (Medicine), FRCP (Glasgow)
Internal Medicine Specialist
M.B.B.S., M.C.P.S
Endocrinologist
MBBS, MRCS, PGD in Endocrinology (UK)
Cardiologist
M.B.B.S, F.C.P.S
Gastroenterologist
M.B.B.S., M.D. (Gastroenterology), M.R.C.P (UK), ESEGH (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.R.C.P (Medicine/Gastro), F.C.P.S. (Gastroenterology ), FRCP, ERCP
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.R.C.P (Medicine/Gastro), F.C.P.S. (Gastroenterology ), FRCP, ERCP
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures